Peptide Modification Diminishes HLA Class II-restricted CD4(+) T Cell Recognition of Prostate Cancer Cells

Prostate cancer poses an ongoing problem in the western world accounting for significant morbidity and mortality in the male population. Current therapy options are effective in treating most prostate cancer patients, but a significant number of patients progress beyond a manageable disease. For the...

Descripción completa

Detalles Bibliográficos
Autores principales: Doonan, Bently P., Amria, Shereen, Bethard, Jennifer R., Banik, Narendra L., Hathaway-Schrader, Jessica D., Haque, Azizul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738740/
https://www.ncbi.nlm.nih.gov/pubmed/36499557
http://dx.doi.org/10.3390/ijms232315234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738740/
https://www.ncbi.nlm.nih.gov/pubmed/36499557
http://dx.doi.org/10.3390/ijms232315234

Ejemplares similares